Single dose oral celecoxib for acute postoperative pain in adults (Q24240843)

3

0 references

Jodie Barden

2

object named as

Jodie Barden

0 references

Robert Andrew Moore

4

object named as

R Andrew Moore

0 references

author name string

Jodie Barden

Cochrane Database of Systematic Reviews

2

0 references

publication date

8 October 2008

0 references

published in

0 references

cites work

Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Efficacy and tolerability of nonprescription ibuprofen versus celecoxib for dental pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

A randomized, clinical trial comparing oral celecoxib 200 mg, celecoxib 400 mg, and ibuprofen 600 mg for acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Relative efficacy of oral analgesics after third molar extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

The visual analogue pain intensity scale: what is moderate pain in millimetres?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Oral aspirin in postoperative pain: a quantitative systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Rofecoxib for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

NSAIDs, coxibs, and the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Gastrointestinal safety of COX-2 specific inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Impact of covert duplicate publication on meta-analysis: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

Single dose oral ibuprofen and diclofenac for postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

7 January 2021

Single dose oral paracetamol (acetaminophen) for postoperative pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

7 January 2021

Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

7 January 2021

Developing a database of published reports of randomised clinical trials in pain research

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

1 reference

7 January 2021

Seeking a simple measure of analgesia for mega-trials: is a single global assessment good enough?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

7 January 2021

Reporting of Adverse Effects in Clinical Trials Should Be Improved

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004233.PUB2

7 January 2021